- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dimerix Ltd (DXB)
Dimerix Ltd stock price live, this page displays ASX DXB stock exchange data. View the DXB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Dimerix Ltd real time stock price chart below.
What Is the Dimerix Ltd Stock Price Today?
The Dimerix Ltd stock price today is 0.165.
What Is the Stock Symbol for Dimerix Ltd?
The stock symbol for Dimerix Ltd is "DXB."
What Stock Exchange Does Dimerix Ltd Trade On?
Dimerix Ltd is listed and trades on the Sydney stock exchange.
Is Dimerix Ltd a Good Stock to Buy?
Determining whether Dimerix Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DXB quote. (ISIN: AU000000DXB7)
What Is the Dimerix Ltd Stock Price Today?
The Dimerix Ltd stock price today is 0.165.
What Is the Stock Symbol for Dimerix Ltd?
The stock symbol for Dimerix Ltd is "DXB."
What Stock Exchange Does Dimerix Ltd Trade On?
Dimerix Ltd is listed and trades on the Sydney stock exchange.
Is Dimerix Ltd a Good Stock to Buy?
Determining whether Dimerix Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DXB quote. (ISIN: AU000000DXB7)
Sydney
Currency in AUD
0.165
-0.005(-2.94%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.165
0.175
52 wk Range
0.158
0.665
DXB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1650.175
52 wk Range
0.1580.665
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DXB Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Feb 25, 2026
EPS / Forecast
-0.03 / --
Revenue / Forecast
2.12M / --
Compare DXB to Peers and Sector
Metrics to compare | DXB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDXBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.1x | −7.4x | −0.5x | |
PEG Ratio | −0.17 | −0.03 | 0.00 | |
Price/Book | −58.9x | 3.1x | 2.6x | |
Price / LTM Sales | 13.4x | 13.5x | 3.0x | |
Upside (Analyst Target) | - | 135.3% | 58.6% | |
Fair Value Upside | Unlock | 1.4% | 10.2% | Unlock |
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is headquartered in Fitzroy, Australia.
Ownership
Ownership Overview
FAQ
What Is the Dimerix (DXB) Stock Price Today?
The Dimerix stock price today is 0.165 AUD.
What Stock Exchange Does Dimerix Trade On?
Dimerix is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Dimerix?
The stock symbol for Dimerix is "DXB."
What Is the Dimerix Market Cap?
As of today, Dimerix market cap is 99.070M AUD.
What Is Dimerix's Earnings Per Share (TTM)?
The Dimerix EPS (TTM) is -0.028.
From a Technical Analysis Perspective, Is DXB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Dimerix Stock Split?
Dimerix has split 10 times.
How Many Employees Does Dimerix Have?
Dimerix has 15 employees.
What is the current trading status of Dimerix (DXB)?
As of Jun 14, 2026, Dimerix (DXB) is trading at a price of 0.165 AUD, with a previous close of 0.170 AUD. The stock has fluctuated within a day range of 0.165 AUD to 0.175 AUD, while its 52-week range spans from 0.158 AUD to 0.665 AUD.
What Is Dimerix (DXB) Price Target According to Analysts?
The average 12-month price target for Dimerix is 1.895 AUD, with a high estimate of 1.895 AUD and a low estimate of 1.895 AUD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,048.48% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.